Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
36.99
-1.51 (-3.92%)
At close: Jul 20, 2026, 4:00 PM EDT
36.83
-0.16 (-0.45%)
After-hours: Jul 20, 2026, 7:57 PM EDT
Vera Therapeutics Employees
Vera Therapeutics had 339 employees as of March 31, 2026. The number of employees increased by 90 or 36.14% since the number was last reported on December 31, 2025.
Employees
339
Change
90
Growth
36.14%
Revenue / Employee
n/a
Profits / Employee
-$1,088,357
Market Cap
2.66B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 339 | 90 | 36.14% |
| Dec 31, 2025 | 249 | 137 | 122.32% |
| Dec 31, 2024 | 112 | 61 | 119.61% |
| Dec 31, 2023 | 51 | 5 | 10.87% |
| Dec 31, 2022 | 46 | 29 | 170.59% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Beam Therapeutics | 522 |
| Tarsus Pharmaceuticals | 370 |
| uniQure | 221 |
| Immunome | 206 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 154 |
| Kodiak Sciences | 130 |
VERA News
- 10 days ago - Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - Vera chief regulatory officer William Turner to retire, Nancy Boman to succeed - TheFly
- 11 days ago - Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner - GlobeNewsWire
- 12 days ago - Vera Therapeutics price target raised to $76 from $56 at Guggenheim - TheFly
- 12 days ago - Vera Therapeutics price target raised to $78 from $73 at TD Cowen - TheFly
- 12 days ago - Vera Therapeutics price target raised to $43 from $35 at Wedbush - TheFly
- 12 days ago - Vera Therapeutics price target raised to $125 from $110 at H.C. Wainwright - TheFly
- 13 days ago - Vera Therapeutics Transcript: FDA announcement - Transcripts